773U82
Alternative Names: BW A773U82Latest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Class Antineoplastics
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Aug 1999 Discontinued-II for Cancer in USA (IV)
- 03 Sep 1998 Profile reviewed
- 13 Apr 1995 Phase-II clinical trials for Cancer in USA (IV)